Construction Materials
Compare Stocks
2 / 10Stock Comparison
AMRZ vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
AMRZ vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Construction Materials | Chemicals - Specialty |
| Market Cap | $31.16B | $232.56B |
| Revenue (TTM) | $11.81B | $34.66B |
| Net Income (TTM) | $1.22B | $7.13B |
| Gross Margin | 25.7% | 46.0% |
| Operating Margin | 16.1% | 28.8% |
| Forward P/E | 19.6x | 28.1x |
| Total Debt | $5.91B | $26.99B |
| Cash & Equiv. | $1.92B | $5.06B |
AMRZ vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Amrize Ltd (AMRZ) | 100 | 110.9 | +10.9% |
| Linde plc (LIN) | 100 | 107.0 | +7.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMRZ vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMRZ is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.32, Low D/E 44.6%, current ratio 1.64x
- Lower P/E (19.6x vs 28.1x)
LIN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 376.9% 10Y total return vs AMRZ's 6.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs AMRZ's 0.9% | |
| Value | Lower P/E (19.6x vs 28.1x) | |
| Quality / Margins | 20.6% margin vs AMRZ's 10.3% | |
| Stability / Safety | Beta 0.24 vs AMRZ's 1.32 | |
| Dividends | 1.2% yield; 6-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +13.6% vs AMRZ's +6.5% | |
| Efficiency (ROA) | 8.3% ROA vs AMRZ's 5.0%, ROIC 11.3% vs 9.2% |
AMRZ vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AMRZ vs LIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 2.9x AMRZ's $11.8B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to AMRZ's 10.3%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $11.8B | $34.7B |
| EBITDAEarnings before interest/tax | $2.8B | $12.1B |
| Net IncomeAfter-tax profit | $1.2B | $7.1B |
| Free Cash FlowCash after capex | $1.4B | $5.1B |
| Gross MarginGross profit ÷ Revenue | +25.7% | +46.0% |
| Operating MarginEBIT ÷ Revenue | +16.1% | +28.8% |
| Net MarginNet income ÷ Revenue | +10.3% | +20.6% |
| FCF MarginFCF ÷ Revenue | +12.0% | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.4% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -34.9% | +13.4% |
Valuation Metrics
AMRZ leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 25.7x trailing earnings, AMRZ trades at a 25% valuation discount to LIN's 34.4x P/E. On an enterprise value basis, AMRZ's 12.5x EV/EBITDA is more attractive than LIN's 20.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $31.2B | $232.6B |
| Enterprise ValueMkt cap + debt − cash | $35.1B | $254.5B |
| Trailing P/EPrice ÷ TTM EPS | 25.68x | 34.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.60x | 28.12x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.36x |
| EV / EBITDAEnterprise value multiple | 12.46x | 20.04x |
| Price / SalesMarket cap ÷ Revenue | 2.64x | 6.84x |
| Price / BookPrice ÷ Book value/share | 2.30x | 5.92x |
| Price / FCFMarket cap ÷ FCF | 21.94x | 45.70x |
Profitability & Efficiency
LIN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $9 for AMRZ. AMRZ carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs AMRZ's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.2% | +17.8% |
| ROA (TTM)Return on assets | +5.0% | +8.3% |
| ROICReturn on invested capital | +9.2% | +11.3% |
| ROCEReturn on capital employed | +8.9% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.45x | 0.68x |
| Net DebtTotal debt minus cash | $4.0B | $21.9B |
| Cash & Equiv.Liquid assets | $1.9B | $5.1B |
| Total DebtShort + long-term debt | $5.9B | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | 5.23x | 34.52x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $10,654 for AMRZ. Over the past 12 months, LIN leads with a +13.6% total return vs AMRZ's +6.5%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.4% vs AMRZ's 2.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -0.1% | +17.3% |
| 1-Year ReturnPast 12 months | +6.5% | +13.6% |
| 3-Year ReturnCumulative with dividends | +6.5% | +41.9% |
| 5-Year ReturnCumulative with dividends | +6.5% | +78.1% |
| 10-Year ReturnCumulative with dividends | +6.5% | +376.9% |
| CAGR (3Y)Annualised 3-year return | +2.1% | +12.4% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than AMRZ's 1.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs AMRZ's 83.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.32x | 0.24x |
| 52-Week HighHighest price in past year | $65.94 | $521.28 |
| 52-Week LowLowest price in past year | $44.12 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +83.3% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 41.3 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 2.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates AMRZ as "Buy" and LIN as "Buy". Consensus price targets imply 20.3% upside for AMRZ (target: $66) vs 7.5% for LIN (target: $540). LIN is the only dividend payer here at 1.20% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $66.11 | $539.71 |
| # AnalystsCovering analysts | 7 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +1.2% |
| Dividend StreakConsecutive years of raises | — | 6 |
| Dividend / ShareAnnual DPS | — | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% |
LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AMRZ leads in 1 (Valuation Metrics).
AMRZ vs LIN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AMRZ or LIN a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus 0. 9% for Amrize Ltd (AMRZ). Amrize Ltd (AMRZ) offers the better valuation at 25. 7x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate Amrize Ltd (AMRZ) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMRZ or LIN?
On trailing P/E, Amrize Ltd (AMRZ) is the cheapest at 25.
7x versus Linde plc at 34. 4x. On forward P/E, Amrize Ltd is actually cheaper at 19. 6x.
03Which is the better long-term investment — AMRZ or LIN?
Over the past 5 years, Linde plc (LIN) delivered a total return of +78.
1%, compared to +6. 5% for Amrize Ltd (AMRZ). Over 10 years, the gap is even starker: LIN returned +376. 9% versus AMRZ's +6. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMRZ or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Amrize Ltd's 1. 32β — meaning AMRZ is approximately 449% more volatile than LIN relative to the S&P 500. On balance sheet safety, Amrize Ltd (AMRZ) carries a lower debt/equity ratio of 45% versus 68% for Linde plc — giving it more financial flexibility in a downturn.
05Which is growing faster — AMRZ or LIN?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus 0. 9% for Amrize Ltd (AMRZ). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -7. 0% for Amrize Ltd. Over a 3-year CAGR, AMRZ leads at 3. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMRZ or LIN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus 10. 0% for Amrize Ltd — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 16. 1% for AMRZ. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMRZ or LIN more undervalued right now?
On forward earnings alone, Amrize Ltd (AMRZ) trades at 19.
6x forward P/E versus 28. 1x for Linde plc — 8. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMRZ: 20. 3% to $66. 11.
08Which pays a better dividend — AMRZ or LIN?
In this comparison, LIN (1.
2% yield) pays a dividend. AMRZ does not pay a meaningful dividend and should not be held primarily for income.
09Is AMRZ or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, AMRZ: +6. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMRZ and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
LIN pays a dividend while AMRZ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.